Top compounds associated with response to RP11-302B13.5


Feature Type Standardized
Nominal ANOVA
mRNA lovastatin CTRPv2 pan-cancer AAC -0.025 0.5
mRNA salermide:PLX-4032 (12:1 mol/mol) CTRPv2 pan-cancer AAC 0.025 0.5
mRNA Carboplatin CTRPv2 pan-cancer AAC -0.024 0.5
mRNA Mitomycin-C CTRPv2 pan-cancer AAC -0.022 0.5
mRNA Methotrexate CTRPv2 pan-cancer AAC 0.024 0.5
mRNA 5-FU CTRPv2 pan-cancer AAC -0.022 0.5
mRNA BRD-K30748066 CTRPv2 pan-cancer AAC -0.075 0.5
mRNA MS-275 CTRPv2 pan-cancer AAC -0.021 0.5
mRNA PD318088 CTRPv2 pan-cancer AAC -0.023 0.5
mRNA BMS-754807 CTRPv2 pan-cancer AAC -0.022 0.5
Download CSV